CRINETICS PHARMACEUTICALS IN

Ticker: CRNX CUSIP: 22663K107 Class: EQTY

Connor, Clark & Lunn Investment Management Ltd.'s Holding History (CIK: 0001596800)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025

Shares 100,567 Value ($000) $4,681 Avg Close $44.52 Range $38.81 - $50.98

Q3 2025

Shares 12,544 Value ($000) $522 Avg Close $31.97 Range $25.83 - $47.41

Q4 2024

Shares 6,898 Value ($000) $353 Avg Close $55.95 Range $49.48 - $62.53

Q3 2024

Shares 20,633 Value ($000) $1,054 Avg Close $51.57 Range $43.71 - $55.78

Q2 2024

Shares 20,128 Value ($000) $902 Avg Close $46.18 Range $41.01 - $53.70

Period	Shares	Value ($000)	Average Close	Price Range
Q4 2025	100,567	$4,681	$44.52	$38.81 - $50.98
Q3 2025	12,544	$522	$31.97	$25.83 - $47.41
Q4 2024	6,898	$353	$55.95	$49.48 - $62.53
Q3 2024	20,633	$1,054	$51.57	$43.71 - $55.78
Q2 2024	20,128	$902	$46.18	$41.01 - $53.70